Dr. Ron Ramirez, MD

Dr. Ramirez practices at Skin Cancer Treatment Center in Pembroke Pines, Florida.

Dr. Ramirez's NPI, 1265810774, was assigned on May 15, 2015. Dr. Ramirez graduated from American University of the Caribbean School of Medicine in 2015. Dr. Ramirez holds Florida license ME136243.

Dr. Ramirez's primary practice is Skin Cancer Treatment Center, at 10001 Pines Blvd, Pembroke Pines, FL 33024 in Broward County. The practice phone is (954) 436-5625.

Dr. Ramirez's primary practice is Skin Cancer Treatment Center in Pembroke Pines, Florida. The medical group on file is Skin Cancer Treatment Center. Dmand AI also links Dr. Ramirez to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ramirez practices. Vendor and product names are available with a free account.

Dermatology is Dr. Ramirez's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Ramirez is board certified in family medicine by the American Board of Family Medicine. Dr. Ramirez is licensed in Florida.

Dmand AI lists acne, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, hives, itchy rashes, scalp rash and skin cyst among the conditions Dr. Ramirez treats.

CMS data shows 3,180 Medicare services from Dr. Ramirez across 16 procedure codes in 2024, for 551 Medicare patients. Medicare paid $289,080 for them. Every service was in an office.

CMS counts 551 Medicare patients who saw Dr. Ramirez in 2024. The largest group is 65 to 74, with 273 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 3% are also on Medicaid. Their average risk score is 1.04, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ramirez's median patient age at 64, with 56% women.

In 2020, Dr. Ramirez wrote 37 Medicare Part D claims. Every claim was for a generic drug. They cover 2 drugs, with $361 in total drug cost. In 2019, CMS named 43 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Ramirez for performance year 2024, reported individually. Dr. Ramirez accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 795 procedures of melanoma (skin cancer) excision by Dr. Ramirez, more than 99% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 38 general payments to Dr. Ramirez from 15 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 78% of the total. Biofrontera Inc. paid the most, $512.

Dr. Ramirez graduated from American University of the Caribbean School of Medicine in 2015.

Dr. Ramirez is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.